Pharmaceutical Dissolution Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512244912

Publication Date:

December 6, 2024

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Due to increased R&D expenditure by pharmaceutical companies as well as an increase in the number of novel medications entering the preclinical stage of development, there has also been an increase in demand for pharmaceutical dissolution testing services.The dissolution testing services were initially disturbed due to the pandemic.
The global market for Pharmaceutical Dissolution Testing Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Dissolution Testing Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharmaceutical Dissolution Testing Services by region & country, by Type, and by Application.
The Pharmaceutical Dissolution Testing Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Dissolution Testing Services.
Market Segmentation
By Company
Intertek Group Plc.
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermofisher Scientific Inc.
Cambrex
Charles River Laboratories
Boston Analytical
Pace Analytical Life Sciences
SOTAX
AMRI
SGS SA
Segment by Type:
In vitro
In vivo
Segment by Application
Capsules
Tablets
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Dissolution Testing Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Pharmaceutical Dissolution Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Pharmaceutical Dissolution Testing Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Pharmaceutical Dissolution Testing Services Product Introduction
1.2 Global Pharmaceutical Dissolution Testing Services Market Size Forecast
1.3 Pharmaceutical Dissolution Testing Services Market Trends & Drivers
1.3.1 Pharmaceutical Dissolution Testing Services Industry Trends
1.3.2 Pharmaceutical Dissolution Testing Services Market Drivers & Opportunity
1.3.3 Pharmaceutical Dissolution Testing Services Market Challenges
1.3.4 Pharmaceutical Dissolution Testing Services Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Dissolution Testing Services Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Dissolution Testing Services Revenue by Company (2019-2024)
2.3 Key Companies Pharmaceutical Dissolution Testing Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pharmaceutical Dissolution Testing Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Pharmaceutical Dissolution Testing Services
2.6 Pharmaceutical Dissolution Testing Services Market Competitive Analysis
2.6.1 Pharmaceutical Dissolution Testing Services Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pharmaceutical Dissolution Testing Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Dissolution Testing Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 In vitro
3.1.2 In vivo
3.2 Global Pharmaceutical Dissolution Testing Services Sales Value by Type
3.2.1 Global Pharmaceutical Dissolution Testing Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Dissolution Testing Services Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Dissolution Testing Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Capsules
4.1.2 Tablets
4.1.3 Others
4.2 Global Pharmaceutical Dissolution Testing Services Sales Value by Application
4.2.1 Global Pharmaceutical Dissolution Testing Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Dissolution Testing Services Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical Dissolution Testing Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Dissolution Testing Services Sales Value by Region
5.1.1 Global Pharmaceutical Dissolution Testing Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Dissolution Testing Services Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Dissolution Testing Services Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Dissolution Testing Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
5.2.2 North America Pharmaceutical Dissolution Testing Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
5.3.2 Europe Pharmaceutical Dissolution Testing Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
5.4.2 Asia Pacific Pharmaceutical Dissolution Testing Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
5.5.2 South America Pharmaceutical Dissolution Testing Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Pharmaceutical Dissolution Testing Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Dissolution Testing Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Dissolution Testing Services Sales Value
6.3 United States
6.3.1 United States Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Dissolution Testing Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Dissolution Testing Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Dissolution Testing Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Dissolution Testing Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
6.5.2 China Pharmaceutical Dissolution Testing Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Dissolution Testing Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Dissolution Testing Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Dissolution Testing Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Dissolution Testing Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Dissolution Testing Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Dissolution Testing Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Dissolution Testing Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Dissolution Testing Services Sales Value, 2019-2030
6.9.2 India Pharmaceutical Dissolution Testing Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Dissolution Testing Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Intertek Group Plc.
7.1.1 Intertek Group Plc. Profile
7.1.2 Intertek Group Plc. Main Business
7.1.3 Intertek Group Plc. Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.1.4 Intertek Group Plc. Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.1.5 Intertek Group Plc. Recent Developments
7.2 Avivia BV
7.2.1 Avivia BV Profile
7.2.2 Avivia BV Main Business
7.2.3 Avivia BV Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.2.4 Avivia BV Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.2.5 Avivia BV Recent Developments
7.3 Almac Group
7.3.1 Almac Group Profile
7.3.2 Almac Group Main Business
7.3.3 Almac Group Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.3.4 Almac Group Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.3.5 Agilent Technologies, Inc. Recent Developments
7.4 Agilent Technologies, Inc.
7.4.1 Agilent Technologies, Inc. Profile
7.4.2 Agilent Technologies, Inc. Main Business
7.4.3 Agilent Technologies, Inc. Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.4.4 Agilent Technologies, Inc. Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.4.5 Agilent Technologies, Inc. Recent Developments
7.5 Catalent, Inc.
7.5.1 Catalent, Inc. Profile
7.5.2 Catalent, Inc. Main Business
7.5.3 Catalent, Inc. Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.5.4 Catalent, Inc. Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.5.5 Catalent, Inc. Recent Developments
7.6 Thermofisher Scientific Inc.
7.6.1 Thermofisher Scientific Inc. Profile
7.6.2 Thermofisher Scientific Inc. Main Business
7.6.3 Thermofisher Scientific Inc. Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.6.4 Thermofisher Scientific Inc. Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.6.5 Thermofisher Scientific Inc. Recent Developments
7.7 Cambrex
7.7.1 Cambrex Profile
7.7.2 Cambrex Main Business
7.7.3 Cambrex Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.7.4 Cambrex Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.7.5 Cambrex Recent Developments
7.8 Charles River Laboratories
7.8.1 Charles River Laboratories Profile
7.8.2 Charles River Laboratories Main Business
7.8.3 Charles River Laboratories Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.8.4 Charles River Laboratories Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.8.5 Charles River Laboratories Recent Developments
7.9 Boston Analytical
7.9.1 Boston Analytical Profile
7.9.2 Boston Analytical Main Business
7.9.3 Boston Analytical Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.9.4 Boston Analytical Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.9.5 Boston Analytical Recent Developments
7.10 Pace Analytical Life Sciences
7.10.1 Pace Analytical Life Sciences Profile
7.10.2 Pace Analytical Life Sciences Main Business
7.10.3 Pace Analytical Life Sciences Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.10.4 Pace Analytical Life Sciences Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.10.5 Pace Analytical Life Sciences Recent Developments
7.11 SOTAX
7.11.1 SOTAX Profile
7.11.2 SOTAX Main Business
7.11.3 SOTAX Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.11.4 SOTAX Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.11.5 SOTAX Recent Developments
7.12 AMRI
7.12.1 AMRI Profile
7.12.2 AMRI Main Business
7.12.3 AMRI Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.12.4 AMRI Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.12.5 AMRI Recent Developments
7.13 SGS SA
7.13.1 SGS SA Profile
7.13.2 SGS SA Main Business
7.13.3 SGS SA Pharmaceutical Dissolution Testing Services Products, Services and Solutions
7.13.4 SGS SA Pharmaceutical Dissolution Testing Services Revenue (US$ Million) & (2019-2024)
7.13.5 SGS SA Recent Developments
8 Industry Chain Analysis
8.1 Pharmaceutical Dissolution Testing Services Industrial Chain
8.2 Pharmaceutical Dissolution Testing Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Dissolution Testing Services Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Dissolution Testing Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Intertek Group Plc.
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermofisher Scientific Inc.
Cambrex
Charles River Laboratories
Boston Analytical
Pace Analytical Life Sciences
SOTAX
AMRI
SGS SA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂